These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11328255)

  • 1. Effect of an enteric-release formulation of naloxone on intestinal transit in volunteers taking codeine.
    Hawkes ND; Richardson C; Evans BK; Rhodes J; Lewis SJ; Thomas GA
    Aliment Pharmacol Ther; 2001 May; 15(5):625-30. PubMed ID: 11328255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related effects of controlled release dihydrocodeine on oro-cecal transit and pupillary light reflex. A study in human volunteers.
    Freye E; Baranowski J; Latasch L
    Arzneimittelforschung; 2001 Jan; 51(1):60-6. PubMed ID: 11215327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.
    Sykes NP
    Palliat Med; 1996 Apr; 10(2):135-44. PubMed ID: 8800821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
    Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
    Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tramadol and tilidine/naloxone on oral-caecal transit and pupillary light reflex.
    Freye E; Latasch L
    Arzneimittelforschung; 2000 Jan; 50(1):24-30. PubMed ID: 10683712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study.
    Gonenne J; Camilleri M; Ferber I; Burton D; Baxter K; Keyashian K; Foss J; Wallin B; Du W; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2005 Aug; 3(8):784-91. PubMed ID: 16234007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
    Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
    Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxegol on whole gut transit in opioid-naïve healthy subjects receiving codeine: A randomized, controlled trial.
    Halawi H; Vijayvargiya P; Busciglio I; Oduyebo I; Khemani D; Ryks M; Rhoten D; Burton D; Szarka LA; Acosta A; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13298. PubMed ID: 29405492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Constipation after tilidine/naloxone and tramadol in comparison to codeine. A dose response study in human volunteers].
    Freye E; Rosenkranz B; Neruda B
    Schmerz; 1996 Oct; 10(5):254-60. PubMed ID: 12799847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose oral naloxone reverses opioid-induced constipation and analgesia.
    Liu M; Wittbrodt E
    J Pain Symptom Manage; 2002 Jan; 23(1):48-53. PubMed ID: 11779668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a fixed-dose opioid agonist/antagonist on constipation in patients on long-term opioids for non-malignant pain unable to tolerate laxatives.
    Mehta V; Alaward S; Kuravinakop S; Nikolic S
    Pain Physician; 2014; 17(5):415-24. PubMed ID: 25247899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of naloxone-3-glucuronide on colonic transit time in healthy men after acute morphine administration: a placebo-controlled double-blinded crossover preclinical volunteer study.
    Netzer P; Sendensky A; Wissmeyer MP; Baumeler S; Batista C; Scheurer U; Krause T; Reber P; Brenneisen R
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1334-41. PubMed ID: 18808445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health.
    Wong BS; Rao AS; Camilleri M; Manabe N; McKinzie S; Busciglio I; Burton DD; Ryks M; Zinsmeister AR
    Aliment Pharmacol Ther; 2010 Oct; 32(7):884-93. PubMed ID: 20839388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone treatment for irritable bowel syndrome--a randomized controlled trial with an oral formulation.
    Hawkes ND; Rhodes J; Evans BK; Rhodes P; Hawthorne AB; Thomas GA
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1649-54. PubMed ID: 12197844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; O'Connor M; Karrison T; Osinski J; Roizen MF; Moss J
    Clin Pharmacol Ther; 2000 Apr; 67(4):398-404. PubMed ID: 10801249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic slow-transit constipation: whole gut transit times, measured by a new simplified method, are not shortened by opioid antagonists.
    Fotherby KJ; Hunter JO
    Aliment Pharmacol Ther; 1987 Aug; 1(4):331-8. PubMed ID: 2979677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slowing of intestinal transit by fat depends on naloxone-blockable efferent, opioid pathway.
    Zhao XT; Wang L; Lin HC
    Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G866-70. PubMed ID: 10859215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral naloxone reverses opioid-associated constipation.
    Meissner W; Schmidt U; Hartmann M; Kath R; Reinhart K
    Pain; 2000 Jan; 84(1):105-109. PubMed ID: 10601678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.